Clinical Application of Recombinant Erythropoietin in Myelodysplasia
- 1 October 1994
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 8 (5) , 993-1009
- https://doi.org/10.1016/s0889-8588(18)30143-6
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Recombinant Human Erythropoietin in the Treatment of Myelodysplastic Syndromes-Response PatternsLeukemia & Lymphoma, 1994
- Investigating Erythropoietin ResistanceNew England Journal of Medicine, 1993
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- Is Recombinant Human Erythropoietin Treatment in Myelodysplastic Syndromes Worthwhile?Leukemia & Lymphoma, 1993
- Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndrome and MyelofibrosisActa Haematologica, 1993
- The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietinBritish Journal of Haematology, 1991
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986